CNMD CONMED Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: CNMD

Price (delayed)

$108.35

Market cap

$3.33B

P/E Ratio

55.85

Dividend/share

$0.8

EPS

$1.94

Enterprise value

$4.31B

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, ...

Highlights
The stock's price to earnings (P/E) is 88% less than its 5-year quarterly average of 486.0
CNMD's equity is up by 11% YoY and by 2.1% from the previous quarter
The net income has soared by 170% year-on-year but it has declined by 34% since the previous quarter
CNMD's EPS has soared by 169% YoY but it is down by 34% QoQ
CNMD's quick ratio is down by 38% YoY and by 5% QoQ
CNMD's gross margin is down by 3.8% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.conmed.com
Peers: BSX MDT TFX SYK

Key stats

What are the main financial stats of CNMD
Market
Shares outstanding
30.75M
Market cap
$3.33B
Enterprise value
$4.31B
Valuations
Price to earnings (P/E)
55.85
Price to book (P/B)
4.18
Price to sales (P/S)
2.85
EV/EBIT
62.24
EV/EBITDA
50.46
EV/Sales
3.69
Earnings
Revenue
$1.17B
EBIT
$69.32M
EBITDA
$85.5M
Free cash flow
$37.5M
Per share
EPS
$1.94
Free cash flow per share
$1.22
Book value per share
$25.9
Revenue per share
$38.01
TBVPS
$27.75
Balance sheet
Total assets
$2.33B
Total liabilities
$1.53B
Debt
$1.01B
Equity
$796.21M
Working capital
$249.33M
Liquidity
Debt to equity
1.27
Current ratio
1.66
Quick ratio
0.69
Net debt/EBITDA
11.49
Margins
EBITDA margin
7.3%
Gross margin
53.6%
Net margin
5%
Operating margin
5.9%
Efficiency
Return on assets
2.5%
Return on equity
7.5%
Return on invested capital
4.6%
Return on capital employed
3.6%
Return on sales
5.9%
Dividend
Dividend yield
0.74%
DPS
$0.8
Payout ratio
41.2%

CNMD stock price

How has the CONMED stock price performed over time
Intraday
-0.09%
1 week
1.97%
1 month
5.68%
1 year
26.25%
YTD
22.24%
QTD
7.44%

Financial performance

How have CONMED's revenue and profit performed over time
Revenue
$1.17B
Gross profit
$625.93M
Operating income
$69.32M
Net income
$57.97M
Gross margin
53.6%
Net margin
5%
The net income has soared by 170% year-on-year but it has declined by 34% since the previous quarter
The company's net margin has surged by 165% YoY but it fell by 36% QoQ
The operating income has increased by 10% since the previous quarter
CNMD's revenue is up by 9% year-on-year and by 2.6% since the previous quarter

Growth

What is CONMED's growth rate over time

Valuation

What is CONMED stock price valuation
CNMD P/E details
P/E
55.85
P/B
4.18
P/S
2.85
EV/EBIT
62.24
EV/EBITDA
50.46
EV/Sales
3.69
CNMD's EPS has soared by 169% YoY but it is down by 34% QoQ
The stock's price to earnings (P/E) is 88% less than its 5-year quarterly average of 486.0
CNMD's equity is up by 11% YoY and by 2.1% from the previous quarter
The stock's price to book (P/B) is 2.6% less than its last 4 quarters average of 4.3 but 2.2% more than its 5-year quarterly average of 4.1
CNMD's revenue is up by 9% year-on-year and by 2.6% since the previous quarter
CNMD's P/S is 8% less than its 5-year quarterly average of 3.1

Efficiency

How efficient is CONMED business performance
The ROE has soared by 167% YoY but it has contracted by 36% from the previous quarter
CNMD's return on assets has surged by 160% year-on-year but it is down by 34% since the previous quarter
CNMD's return on invested capital is up by 12% since the previous quarter
CNMD's ROS is up by 5% QoQ

Dividends

What is CNMD's dividend history
Dividend details
DPS
$0.8
Dividend yield
0.74%
Payout ratio
41.2%
Recent dividends

Financial health

How did CONMED financials performed over time
CNMD's total assets is 52% greater than its total liabilities
The current ratio has contracted by 40% YoY and by 4.6% from the previous quarter
CNMD's quick ratio is down by 38% YoY and by 5% QoQ
The company's debt is 27% higher than its equity
The company's debt to equity fell by 12% YoY and by 4.5% QoQ
CNMD's equity is up by 11% YoY and by 2.1% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.